Evidence map›Paper›PMID 29534563›Full record

ArticleACS infectious diseases2018

Antibiotic Combinations That Enable One-Step, Targeted Mutagenesis of Chromosomal Genes.

Wonsik Lee, Truc Do, Ge Zhang, Daniel Kahne, Timothy C Meredith, Suzanne Walker

Abstract read
In one paragraph

Article in ACS infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Recent Advances in Genetic Tools forFrontiers in genetics · 2020
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wonsik LeeDepartment of Microbiology and Immunobiology , Harvard Medical School , 4 Blackfan Circle , Boston , Massachusetts 02115 , United States.
Truc DoDepartment of Microbiology and Immunobiology , Harvard Medical School , 4 Blackfan Circle , Boston , Massachusetts 02115 , United States.
Ge ZhangDepartment of Microbiology and Immunobiology , Harvard Medical School , 4 Blackfan Circle , Boston , Massachusetts 02115 , United States.
Daniel KahneDepartment of Chemistry and Chemical Biology , Harvard University , 12 Oxford Street , Cambridge , Massachusetts 02138 , United States.ORCID 0000-0002-8296-1424
Timothy C MeredithDepartment of Microbiology and Immunobiology , Harvard Medical School , 4 Blackfan Circle , Boston , Massachusetts 02115 , United States.
Suzanne WalkerDepartment of Microbiology and Immunobiology , Harvard Medical School , 4 Blackfan Circle , Boston , Massachusetts 02115 , United States.ORCID 0000-0002-0545-914X
Harvard University · US

Funding

Technical Mother Machine CoreP01AI083214 · NIAID · SCHEPENS EYE RESEARCH INSTITUTE · PI Michael S Gilmore · 2009 to 2026
$39.4M
Targeting bacterial cell wall biogenesis for the development of novel antimicrobU19AI109764 · NIAID · HARVARD MEDICAL SCHOOL · PI KASPER, DENNIS L. · 2014 to 2018
$25.2M
NIAID NIH HHS P01 AI083214NIAID NIH HHS U19 AI109764
6 · The paper itself

Abstract

Targeted modification of bacterial chromosomes is necessary to understand new drug targets, investigate virulence factors, elucidate cell physiology, and validate results of -omics-based approaches. For some bacteria, reverse genetics remains a major bottleneck to progress in research. Here, we describe a compound-centric strategy that combines new negative selection markers with known positive selection markers to achieve simple, efficient one-step genome engineering of bacterial chromosomes. The method was inspired by the observation that certain nonessential metabolic pathways contain essential late steps, suggesting that antibiotics targeting a late step can be used to select for the absence of genes that control flux into the pathway. Guided by this hypothesis, we have identified antibiotic/counterselectable markers to accelerate reverse engineering of two increasingly antibiotic-resistant pathogens, Staphylococcus aureus and Acinetobacter baumannii. For S. aureus, we used wall teichoic acid biosynthesis inhibitors to select for the absence of tarO and for A. baumannii, we used colistin to select for the absence of lpxC. We have obtained desired gene deletions, gene fusions, and promoter swaps in a single plating step with perfect efficiency. Our method can also be adapted to generate markerless deletions of genes using FLP recombinase. The tools described here will accelerate research on two important pathogens, and the concept we outline can be readily adapted to any organism for which a suitable target pathway can be identified.

Indexed as

Chromosomes, BacterialGenes, BacterialMutagenesisAcinetobacter baumanniiAnti-Bacterial AgentsBacterial ProteinsDrug DesignDrug DiscoveryGenetic EngineeringGenetic LociMethicillin-Resistant Staphylococcus aureusModels, BiologicalMolecular StructureRecombination, GeneticSelection, GeneticAnti-Bacterial AgentsBacterial Proteinsbacterial geneticschemical geneticshomologous recombinationnegative selectionpathway inhibitors

Identifiers

PMID29534563
PMCPMC5993608
OpenAlexW2789632217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.